4,4-Dimethylcyclohexanone

Catalog No.: 
ACDYRM206
CAS No.: 
4255-62-3
Molecular Formula: 
C8H14O
Molecular Weight: 
126.20
4,4-Dimethylcyclohexanone structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4,4-Dimethylcyclohexanone
IUPAC Name4,4-dimethylcyclohexan-1-one
MDL No.MFCD00234965
Molecular FormulaC8H14O
Molecular Weight126.20
SMILESC1(CCC(CC1)=O)(C)C
InChI KeyPXQMSTLNSHMSJB-UHFFFAOYSA-N
SynonymSB40536 | F9994-0706 | 4.4-dimethylcyclohexanone | MFCD00234965 | SCHEMBL307642 | 4,4-Dimethylcyclohexanone | 4,4-dimethyl-cyclohexanone | HY-W002564 | AKOS005255849 | 4-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-4-keto-butyric acid | BCP07623 | CS-W0
CAS No.4255-62-3
PubChem CID138166

Safety Data

Pictogram
FlammableHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H228-H319
Precautionary Statement(s)
P210-P240-P264-P280-P305+P351+P338-P337+P313-P370+P378-P403+P233-P501

Synthetic Route by SureRoute

1. ACDYRM206 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBODL461 route compound structure diagram
    ACBODL4611073-13-8In Stock
  2. Then
  3. ACDYRM206 route product structure diagram
    ACDYRM2064255-62-3
Inquiry

2. ACDYRM206 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBODL461 route compound structure diagram
    ACBODL4611073-13-8In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDYRM206 route product structure diagram
    ACDYRM2064255-62-3
Inquiry

3. ACDYRM206 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDYRM206 route product structure diagram
    ACDYRM2064255-62-3
Inquiry

Comments (0)